Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • brentp
    Member
    • Apr 2010
    • 72

    #1

    DESeq on BS-Seq data

    Hi, would it be reasonable to use DESeq on Bisulfite data?

    I was thinking of using counts of the number of unconverted Cytosines (for different treatments) covering each gene as the input.
    Any reason I should *not* do that?
    Any thing I should be aware of in doing so?

    Thanks,
    Brent
  • brentp
    Member
    • Apr 2010
    • 72

    #2
    Or perhaps the counts would be better as number of Cytosines with > X% methylation within a gene?

    Comment

    • Wolfgang Huber
      Senior Member
      • Aug 2009
      • 109

      #3
      Dear Brent

      probably the answer is yes, but "use DESeq on Bisulfite data" is vague, and it will be good to first clarify: what is the biological question that you want to answer with this? How do you translate it into the hypothesis test(s) of DESeq?

      Whatever you do, can you first apply it to a comparison between biological replicates ("as if" they were the two conditions that you want to compare) and make sure that the type-I error (false positive rate or false discovery) is as advertised?

      Best wishes
      Wolfgang
      Wolfgang Huber
      EMBL

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...